Mode
Text Size
Log in / Sign up
N/A N=251 Randomized Supportive Care

Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer Patients

Breast Cancer

Enrolled (actual)
251
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcome: Primary: Missed Fractions

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Supervised, individualized exercise oncology program (Other); Current standard of care (Other)
Age
Adult, Older Adult · 30+ yrs
Sex
Female
Sponsor
Karen Wonders
Primary completion
Oct 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Missed Fractions
PRIMARY
Numbers of Breaks in Cancer Treatment
PRIMARY
Cost of Emergency Room Visits
661; 989
PRIMARY
Encounters
7; 12
PRIMARY
Cost of Total Unplanned Expenditures
PRIMARY
Cost of Hospital Inpatient Care
PRIMARY
Cancer Treatment Adherence
PRIMARY
Cancer Treatment Symptom Management Medications
PRIMARY
Cancer Treatment Related Side Effects
PRIMARY
Patient Rated Pain Score
50.4; 50.5; 62.3; 49.7
PRIMARY
Cancer TreatmentTtolerance
57; 51; 15; 14; 46; 45
PRIMARY
Quality of Life Measure: Utilizing McGill Quality of Life Survey and FACT-B Questionnaire
19.1; 19.2; 23.1; 19.2; 19.6; 19.5
SECONDARY
Adherence Rate
95
SECONDARY
Percentage of Participants Who Completed the Study (Attrition Rate)
95.3; 98.3

Summary

To test the effect of an individualized exercise oncology program on healthcare utilization, 30-day hospital readmission, pain, and cancer treatment tolerance.

Eligibility Criteria

Inclusion Criteria

  • Female; determined from electronic medical record
  • Initial stage 0, 1 or 2 breast cancer diagnosis within the past 12 weeks determined from electronic medical record
  • Age 30-80; determined from electronic medical record
  • Physician clearance to participate in exercise

Exclusion Criteria

  • Participation in supervised physical exercise within 6 months prior to study enrollment
  • Currently pregnant or planning to become pregnant
  • Non-English speaking
  • Unable to make own medical decisions and/or to follow verbal instructions
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04106609). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search